Annual Meeting Agenda
This year's general session focuses on the latest science, surgical innovations, and practice-changing information for breast surgeons. We've planned a variety of learning opportunities and networking events, and more will be added in the weeks ahead! Arrive early to participate in our Pre-Meeting Program — courses begin Wednesday, April 30.
Wednesday, April 30
Pre-Meeting Courses
Wed, April 30, 8:00 AM – 5:00 PM
*Limited Enrollment*
Learn MoreThursday, May 1
Pre-Meeting Courses
Thu, May 1, 7:00 AM – 1:00 PM
*Limited Enrollment*
Learn MoreWelcome
Thu, May 1, 1:00 PM – 1:15 PM
Presenters: Judy C. Boughey, MD, FACS; Kari M. Rosenkranz, MD, FACS
Coding, Reimbursement, and Quality Symposium
Thu, May 1, 1:15 PM – 2:30 PM
Moderators: Richard E. Fine, MD, FACS; Walton A. Taylor, MD, FACS
-
Coding and Reimbursement
Linda K. Han, MD, FACS, FSSO -
Coding and Reimbursement Panel Q&A
Richard E. Fine, MD, FACS; Linda K. Han, MD, FACS, FSSO; Walton A. Taylor, MD, FACS -
EUSOMA Quality Indicators
Isabel T. Rubio, MD, PhD -
NAPBC Quality Measures and Standards
Paul L. Baron, MD, FACS -
Q&A
Scientific Oral Presentations 1
Thu, May 1, 2:30 PM – 3:15 PM
Moderators: Sarah L. Blair, MD, FACS; Megan Miller, MD, FACS
Multidisciplinary Communication in the Era of De-escalation
Thu, May 1, 3:15 PM – 4:15 PM
Moderators: Giacomo Montagna, MD, MPH, FACS; Alyssa D. Throckmorton, MD, FACS
-
Welcome and Introduction
Giacomo Montagna, MD, MPH, FACS; Alyssa D. Throckmorton, MD, FACS -
What to Omit and When: Management of ER+ HER- Axillary Disease
Rachel L. McCaffrey, MD, FACS -
CDK4/6 Inhibition: What Do Surgeons Need to Know?
Austin D. Williams, MD, MSEd, FACS -
Omission of Radiation With Nodal pCR to Neoadjuvant Chemotherapy
Jennifer K. Plichta, MD, MS, FACS -
Omission of Surgery After Neoadjuvant Chemotherapy
Isabel T. Rubio, MD, PhD -
Q&A
Outside the Clinical Trials
Thu, May 1, 4:15 PM – 5:00 PM
Moderators: Richard J. Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD
-
Welcome and Introduction
Richard J. Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD -
Evidence for Complementary and Alternative Medicine (CAM)
Theresa L. Schwartz, MD, MS, FACS -
Ethics of Complementary and Alternative Medicine (CAM)
Jennifer H. Fieber, MD, FACS -
Spirituality and Religion
Katherina Zabicki Calvillo, MD, FACS -
Q&A
Debate: DCIS Should Be Managed With Observation Alone
Thu, May 1, 5:00 PM – 5:30 PM
Non-CME
Moderators: Kari J. Kansal, MD, FACS; Alastair M. Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS
-
Welcome and Introduction
Kari J. Kansal, MD, FACS; Alastair M. Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS -
Pro: Observation for DCIS
E. Shelley Hwang, MD, MPH, FACS -
Con: Surgical Resection for DCIS
Kimberly J. Van Zee, MS, MD, FACS -
Take Home Message for DCIS Management in 2025
Anna Weiss, MD, FACS
Evening Industry Symposia
Thu, May 1, 5:30 PM – 7:00 PM
Non-CME
Friday, May 2
Welcome
Fri, May 2, 8:00 AM – 8:15 AM
Presenters: Judy C. Boughey, MD, FACS; Kari M. Rosenkranz, MD, FACS
Debate: Contralateral Prophylactic Mastectomy
Fri, May 2, 8:15 AM – 9:00 AM
Moderators: Rachel A. Greenup, MD, MPH, FACS; Paige Teller, MD, FACS
-
Welcome and Introduction
Rachel A. Greenup, MD, MPH, FACS; Paige Teller, MD, FACS -
Pro Contralateral Prophylactic Mastectomy
Lee G. Wilke, MD, FACS -
Against Contralateral Prophylactic Mastectomy
Funda Meric-Bernstam, MD, FACS -
Summary and Best Practice for Contralateral Prophylactic Mastectomy in 2025
Laura S. Dominici, MD, FACS -
International Perspective on Contralateral Prophylactic Mastectomy
Marie Jeanne Vrancken Peeters, MD, PhD
Invasive Lobular Breast Cancer: It Isn’t Just Ductal
Fri, May 2, 9:00 AM – 10:00 AM
Moderators: Anna C. Beck, MD; Lillian M. Erdahl, MD, FACS
-
Welcome and Introduction
Anna C. Beck, MD; Lillian M. Erdahl, MD, FACS -
Welcome and Introduction
Evelyn F. Carroll, MD -
Genetics and Invasive Lobular Carcinoma
Lauren A. Gamble, MD -
Surgical Management of the Breast in Invasive Lobular Carcinoma
Rita A. Mukhtar, MD, FACS -
Surgical Management of the Axilla in Invasive Lobular Carcinoma
Michael R. Cassidy, MD, FACS -
Neoadjuvant Therapy for Invasive Lobular Carcinoma
Meghan R. Flanagan, MD, MPH, FACS -
Q&A
“How I Do It” Videos and Late Breaking Abstracts
Fri, May 2, 10:00 AM – 10:30 AM
Moderators: Katrina B. Mitchell, MD, IBCLC, FACS; Courtney A. Vito, MD, FACS
Break in the Exhibit Hall
Fri, May 2, 10:30 AM – 11:00 AM
Non-CME
Debate: Is Breast Conservation Safer Than Mastectomy?
Fri, May 2, 11:00 AM – 11:45 AM
Moderators: Christine Laronga, MD, FACS; Jennifer E. Tonneson, MD, FACS
-
Welcome and Introduction
Christine Laronga, MD, FACS; Jennifer E. Tonneson, MD, FACS -
Pro Mastectomy
Kandace P. McGuire, MD, FACS -
Pro Breast Conservation Therapy
Mahmoud El-Tamer, MD, FACS -
Summary and Best Practice of Breast Conservation vs Mastectomy in 2025
Stephanie Downs-Canner, MD, FACS -
Ethics of Shared Decision Making in Era as Data Evolve
Puneet Singh, MD, FACS
Keynote Address
Fri, May 2, 11:45 AM – 12:45 PM
-
Keynote Address Introduction
Judy C. Boughey, MD, FACS -
Keynote Address: “Re-imagining Stage 0 and 1 Breast Cancer”
Bruce Mann, MBBS, PhD, FRACS
Lunch in the Exhibit Hall
Fri, May 2, 12:45 PM – 1:45 PM
Non-CME
Maximizing Your Breast Surgery Practice
Fri, May 2, 1:45 PM – 2:30 PM
Moderators: Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS
-
Welcome and Introduction
Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS -
Optimizing APPs in a Successful Breast Practice
Kimberly A. Hoskins, NP; Melissa Pilewskie, MD, FACS -
Quality of Care: Institutional and Individual Surgeon Assessments
Richard L. White, Jr., MD, FACS -
Industry Relationships: Navigating the Value and Challenges
Sarah A. McLaughlin, MD, FACS -
Q&A
Scientific Oral Presentations 2
Fri, May 2, 2:30 PM – 3:45 PM
Moderators: Catherine C. Parker, MD, FACS; Mediget Teshome, MD, MPH, FACS
Break in Exhibit Hall
Fri, May 2, 3:45 PM – 4:15 PM
Non-CME
Cultural Competencies in Breast Surgery
Fri, May 2, 4:15 PM – 5:00 PM
Moderators: Alaina D. Geary, MD, MHPE; Lauren M. Postlewait, MD, FACS
-
Welcome and Introduction
Alaina D. Geary, MD, MHPE; Lauren M. Postlewait, MD, FACS -
Cultural Awareness in the Care of Breast Cancer Patients
Olga Kantor, MD, FACS -
Screening for Breast Cancer in the Transgender Population
Evelyn F. Carroll, MD -
Management of High-Risk and Breast Cancer in the Transgender Population
Chandler S. Cortina, MD, MS, FSSO, FACS -
Racial Disparities in Access and Outcomes for Women with Breast Cancer
Shon M. Black, MD, FACS, FSSO -
Financial Toxicity
Mary L. Gemignani, MD, MPH, FACS -
Q&A
Quickshots Presentations
Fri, May 2, 5:00 PM – 6:00 PM
Moderators: Carla S. Fisher, MD, MBA, FACS; Marissa M. Howard-McNatt, MD, FACS
Saturday, May 3
Hoag Hospital Surgical Innovation Forum: Innovative Surgical Techniques
Sat, May 3, 8:00 AM – 9:00 AM
Moderators: Julie A. Billar, MD; Abhishek Chatterjee, MD, MBA, FACS
-
Welcome and Introduction
Julie A. Billar, MD; Abhishek Chatterjee, MD, MBA, FACS -
Robotic Mastectomy
Mara A. Piltin, DO, FACS -
Lymphovenous Bypass and Lymph Node Transfer
Zahraa Al-Hilli, MD, MBA, FACS, FRCSI -
Extreme Oncoplasty
Kristalyn K. Gallagher, DO, FACOS, FACS -
Minimally Invasive Vacuum Assisted Excision for Small Cancers and 3D Images for Surgical Planning
Stuart A. McIntosh, MBChB, PhD -
Advances in Breast Reconstruction
Scott T. Hollenbeck, MD, FACS -
Q&A
Scientific Oral Presentations 3
Sat, May 3, 9:00 AM – 10:00 AM
Moderators: Leslie L. Montgomery, MD, FACS, FSSO; Candice Sauder, MD, MEd, FACS
Break in the Exhibit Hall
Sat, May 3, 10:00 AM – 10:30 AM
Non-CME
2024 Best Papers
Sat, May 3, 10:30 AM – 11:30 AM
-
Welcome and Introduction
Kari M. Rosenkranz, MD, FACS -
2024 Best Papers
Helen A. Pass, MD, FACS
Presidential Address
Sat, May 3, 11:30 AM – 12:30 PM
-
Presidential Address Introduction
Michael P. Berry, MD, FACS -
Presidential Address
Judy C. Boughey, MD, FACS
Lunch in the Exhibit Hall
Sat, May 3, 12:30 PM – 1:30 PM
Non-CME
Multidisciplinary Care and Tumor Biology
Sat, May 3, 1:30 PM – 3:00 PM
Moderators: Elizabeth A. Mittendorf, MD, PhD, FACS; Jamie L. Wagner, DO, MBA, FACOS, FACS
-
Welcome and Introduction
Elizabeth A. Mittendorf, MD, PhD, FACS; Jamie L. Wagner, DO, MBA, FACOS, FACS -
Debate: All Patients Should Be Treated With Neoadjuvant Systemic Therapy Followed by Surgery
Laura J. Esserman, MD, MBA, FACS -
Standard of Care Remains Upfront Surgery Followed by Systemic Therapy
Mehra Golshan, MD, MBA FACS -
Optimal Management Strategy in 2025
Mediget Teshome, MD, MPH, FACS -
Indications and Benefits of Immunotherapy: Triple-negative Breast Cancer and Luminal Breast Cancer
Julia Tchou, MD, PhD, FACS -
Perioperative Management of Patients on Immunotherapy: Important Information for Surgeons and Anethesia
Tina J. Hieken, MD, FACS -
Q&A
-
Debate: Axillary Lymph Node Dissection Is Recommended After Neoadjuvant Chemotherapy for Residual Node Positive Disease
Marie Jeanne Vrancken Peeters, MD, PhD -
Radiation Therapy Can Replace Axillary Lymph Node Dissection for Residual Node Positive Disease After Neoadjuvant Chemotherapy
Walter P. Weber, MD -
Management of Residual Node Positive Disease in 2025 While We Await More Data
Kelly K. Hunt, MD, FACS -
Q&A
Break in the Exhibit Hall
Sat, May 3, 3:00 PM – 3:30 PM
Non-CME
Your ASBrS: We Are Your Society
Sat, May 3, 3:30 PM – 4:30 PM
-
Annual Business Meeting
-
2024-2025 ASBrS Year in Review
Judy C. Boughey, MD, FACS -
Changes in Breast Surgical Oncology Fellowship Training Experience Over the Years
Andrea Madrigrano, MD -
Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants and Program Directors Preferences Regarding In-Person vs Virtual Interviews
Jennifer K. Plichta, MD, MS, FACS -
Oral Presentation and Poster Presentation Awards
Sarah L. Blair, MD, FACS -
Recognition of Newly Certified Individuals
Michele M. Carpenter, MD, FACS; Nicole Demos, PA-C -
Meet the ASBrS Board and Staff and Awards Presentation
Management of Unique Populations
Sat, May 3, 4:30 PM – 5:30 PM
Moderators: Lesly A. Dossett, MD, MPH, FACS; Susan B. Kesmodel, MD, FACS
-
Welcome and Introduction
Lesly A. Dossett, MD, MPH, FACS; Susan B. Kesmodel, MD, FACS -
Elderly: When to Stop Screening, Omission of Surgery (endocrine therapy alone vs cyroblation)
Ingrid M. Lizarraga, MBBS, FACS -
Pregnant Patient and Pregnancy After Breast Cancer
Jacqueline Jeruss, MD, PhD, FACS -
Recurrent Breast Cancer
Mary M. Mrdutt, MD, MS, FACS -
Adolescent and Young Adults: Management and Survivorship
Candice Sauder, MD, MEd, FACS -
Male Breast Cancer
Lucy M. De La Cruz, MD, FACS -
Q&A
Communicating With Our Patients
Sat, May 3, 5:30 PM – 6:15 PM
Moderators: Vivian J. Bea, MD, MBS, FACS; Jillian K. Smith, MD, MPH, FACS
-
Welcome and Introduction
Vivian J. Bea, MD, MBS, FACS; Jillian K. Smith, MD, MPH, FACS -
Patient Perspective
Amanda Echalaz, BMus Hons -
Empathy is Not as Easy as It Sounds
Rakhshanda Layeequr Rahman, MD, FACS -
Shared Decision-Making Tools
Julie A. Margenthaler, MD, FACS -
Integrating Patient-reported Outcomes Into Patient Counseling
Sarah Tevis, MD, FACS -
Q&A
ASBrS 2025 Gala
Sat, May 3, 7:15 PM – 9:30 PM
Non-CME
Sunday, May 4
Axillary Management in 2025 and Beyond
Sun, May 4, 8:00 AM – 9:00 AM
Moderators: Steven Cai, MD, FACS; Jennifer K. Plichta, MD, MS, FACS
-
Welcome and Introduction
Steven Cai, MD, FACS; Jennifer K. Plichta, MD, MS, FACS -
Axillary Surgery in the Clinically Negative Axilla in Patients Undergoing Upfront Surgery?
Oluwadamilola “Lola” M. Fayanju, MD, MA, MPHS, FACS -
Axillary Surgery for Patients With Ultrasound Biopsy Positive Node(s) [cN1 disease] Undergoing Upfront Surgery
Akiko Chiba, MD, FACS -
Axillary Management of 1-2 Positive Nodes After Treatment With Neoadjuvant Endocrine Therapy
Arielle P. Stafford, MD, FACS -
Is Axillary Lymph Node Dissection Required in cN2/N3 Disease with Imaging Response After Neoadjuvant Systemic Therapy?
Roshni Rao, MD, FACS -
Omission of Radiation in cN+ Disease with Response to Neoadjuvant Systemic Therapy
Bruce G. Haffty, MD FACR FASTRO FASCO -
Q&A
ASBrS Benign Breast Disease Guidelines
Sun, May 4, 9:00 AM – 10:00 AM
Moderators: Katrina B. Mitchell, MD, IBCLC, FACS; Helen A. Pass, MD, FACS; Katharine A. Yao, MD, FACS
-
Welcome and Introduction
Helen A. Pass, MD, FACS; Katharine A. Yao, MD, FACS -
Fibroadenoma and Fibroepithelial Lesions and Benign Phyllodes
Lorraine Tafra, MD, FACS -
Idiopathic Granulomatous Mastitis, Lactational Mastitis and Squamous Metaplasia of the Lactiferous Ducts
Katrina B. Mitchell, MD, IBCLC, FACS -
Atypia and Lobular Carcinoma in Situ
Tari A. King, MD, FACS, FSSO -
Other Benign Lesions
Amanda L. Amin, MD, MS, FACS -
Q&A
Key Updates From National and International Meetings
Sun, May 4, 10:00 AM – 11:00 AM
Moderators: Toan T. Nguyen, MD, FACS; Shayna L. Showalter, MD, FACS
-
Welcome and Introduction
Toan T. Nguyen, MD, FACS; Shayna L. Showalter, MD, FACS -
ASCO
Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO -
San Antonio
Henry M. Kuerer, MD, PhD, FACS -
ASTRO
Bruce G. Haffty, MD FACR FASTRO FASCO -
St Gallen
Walter P. Weber, MD -
The Lancet Breast Cancer Commission
Stuart A. McIntosh, MBChB, PhD -
Q&A
Closing Ceremony: Vision of ASBrS for 2025-2026
Sun, May 4, 11:00 AM – 11:15 AM
Presenters: Michael P. Berry, MD, FACS; Judy C. Boughey, MD, FACS
